Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)

Virology

Volumn 329, Issue 1, 2004, Pages 11-17

  Sainz Jr , Bruno ^a   Mossel, Eric C ^b   Peters, C J ^b   Garry, Robert F ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Coronavirus; Interferon beta; Interferon gamma

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; SARS CORONAVIRUS; VERO CELL; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON TYPE II; INTERFERON-BETA; L CELLS (CELL LINE); MICE; SARS VIRUS; VERO CELLS; VIRUS REPLICATION;

CORONAVIRUS; DNA VIRUSES;

EID: 5144219591     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.08.011     Document Type: Article

References (20)

1. M. Asper, T. Sternsdorf, M. Hass, C. Drosten, A. Rhode, H. Schmitz, and S. Gunther Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus J. Virol. 78 6 2004 3162 3169
2. M.C. Berenbaum What is synergy? Pharmacol. Rev. 41 2 1989 93 141
3. J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H.W. Doerr Treatment of SARS with human interferons Lancet 362 9380 2003 293 294
4. S.D. Der, A. Zhou, B.R. Williams, and R.H. Silverman Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proc. Natl. Acad. Sci. U.S.A. 95 26 1998 15623 15628
5. C. Drosten, S. Gunther, W. Preiser, S. van der Werf, H.R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R.A. Fouchier, A. Berger, A.M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J.C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H.D. Klenk, A.D. Osterhaus, H. Schmitz, and H.W. Doerr Identification of a novel coronavirus in patients with severe acute respiratory syndrome N. Engl. J. Med. 348 20 2003 1967 1976 (Electronic publication 2003 Apr 10.)
6. T. Fujii, T. Nakamura, and A. Iwamoto Current concepts in SARS treatment J. Infect. Chemother. 10 1 2004 1 7
7. S. Goodbourn, L. Didcock, and R.E. Randall Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures J. Gen. Virol. 81 Pt. 10 2000 2341 2364
8. Y. Guan, B.J. Zheng, Y.Q. He, X.L. Liu, Z.X. Zhuang, C.L. Cheung, S.W. Luo, P.H. Li, L.J. Zhang, Y.J. Guan, K.M. Butt, K.L. Wong, K.W. Chan, W. Lim, K.F. Shortridge, K.Y. Yuen, J.S. Peiris, and L.L. Poon Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China Science 302 5643 2003 276 278 (Electronic publication 2003 Sep 4.)
9. B.L. Haagmans, T. Kuiken, B.E. Martina, R.A. Fouchier, G.F. Rimmelzwaan, G. van Amerongen, D. van Riel, T. de Jong, S. Itamura, K.H. Chan, M. Tashiro, and A.D. Osterhaus Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques Nat. Med. 10 3 2004 290 293 (Electronic publication 2004 Feb 22.)
10. L.E. Hensley, L.E. Fritz, P.B. Jahrling, C.L. Karp, J.W. Huggins, and T.W. Geisbert Interferon-beta 1a and SARS coronavirus replication Emerging Infect. Dis. 10 2 2004 317 319
11. T.G. Ksiazek, D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J.A. Comer, W. Lim, P.E. Rollin, S.F. Dowell, A.E. Ling, C.D. Humphrey, W.J. Shieh, J. Guarner, C.D. Paddock, P. Rota, B. Fields, J. DeRisi, J.Y. Yang, N. Cox, J.M. Hughes, J.W. LeDuc, W.J. Bellini, and L.J. Anderson A novel coronavirus associated with severe acute respiratory syndrome N. Engl. J. Med. 348 20 2003 1953 1966
12. J. Larkin, L. Jin, M. Farmen, D. Venable, Y. Huang, S.L. Tan, and J.I. Glass Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system J. Interferon Cytokine Res. 23 5 2003 247 257
13. W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, H. Choe, and M. Farzan Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 6965 2003 450 454
14. M.R. Loutfy, L.M. Blatt, K.A. Siminovitch, S. Ward, B. Wolff, H. Lho, D.H. Pham, H. Deif, E.A. LaMere, M. Chang, K.C. Kain, G.A. Farcas, P. Ferguson, M. Latchford, G. Levy, J.W. Dennis, E.K. Lai, and E.N. Fish Interferon alfacon-1 plus corticosteroids in SARS: a preliminary study JAMA 290 24 2003 3222 3228
15. J.S. Peiris, S.T. Lai, L.L. Poon, Y. Guan, L.Y. Yam, W. Lim, J. Nicholls, W.K. Yee, W.W. Yan, M.T. Cheung, V.C. Cheng, K.H. Chan, D.N. Tsang, R.W. Yung, T.K. Ng, and K.Y. Yuen Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 9366 2003 1319 1325
16. L.M. Pfeffer, C.A. Dinarello, R.B. Herberman, B.R. Williams, E.C. Borden, R. Bordens, M.R. Walter, T.L. Nagabhushan, P.P. Trotta, and S. Pestka Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons Cancer Res. 58 12 1998 2489 2499
17. B. Sainz Jr., and W.P. Halford Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1 J. Virol. 76 22 2002 11541 11550
18. M. Spiegel, A. Pichlmair, E. Muhlberger, O. Haller, and F. Weber The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA protein J. Clin. Virol. 30 3 2004 211 213
19. U. Stroher, A. DiCaro, Y. Li, J.E. Strong, F. Aoki, F. Plummer, S.M. Jones, and H. Feldmann Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha J. Infect. Dis. 189 7 2004 1164 1167 (Electronic publication 2004 Mar 12.)
20. B.J. Zheng, K.H. Wong, J. Zhou, K.L. Wong, B.W. Young, L.W. Lu, and S.S. Lee SARS-related virus predating SARS outbreak, Hong Kong Emerging Infect. Dis. 10 2 2004 176 178